UCBJY
Price:
$144.0872
Market Cap:
$48.05B
UCB S.A. is a biopharmaceutical enterprise dedicated to developing innovative treatments and solutions for individuals living with neurological and immunological diseases. Its primary product, Cimzia, addresses a spectrum of inflammatory TNF-mediated conditions, encompassing ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis. For epilepsy management, the company provides Vimpat, Keppra, and Briviact, alongside Nayzilam, an emergency nasal spray for seizure clusters. Neupro is offered for Parkinson's disease and restless legs syndrome, while Zyrtec and Xyzal alleviate aller...[Read more]
Industry
Biotechnology
IPO Date
2012-08-03
Stock Exchange
OTC
Ticker
UCBJY
Dividends are a key part of long-term returns for investors, and UCB S.A. (UCBJY) has a track record worth reviewing. Looking at dividend history for UCBJY gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2026-05-05
Dividend Yield
0.40%
Annual Dividend
$0.85
P/E Ratio
31.05
Payout Ratio
0.17
Dividend per Share
$1.01
EPS
4.64
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2026-05-05 | $0.85035 | $0.85035 | 2026-05-26 | 2026-04-23 |
| 2025-04-28 | $0.79042 | $0.79042 | 2025-05-14 | 2025-04-16 |
| 2024-04-26 | $0.72801 | $0.725 | 2024-05-15 | 2024-04-18 |
| 2023-05-01 | $0.73203 | $0.726 | 2023-05-18 | 2023-04-11 |
| 2022-04-29 | $0.702 | $0.702 | 2022-05-18 | 2022-04-23 |
| 2021-05-07 | $0.76257 | $0.769 | 2021-05-19 | 2021-04-30 |
| 2020-05-04 | $0.6691 | $0.6691 | 2020-05-21 | 2020-04-24 |
| 2019-04-26 | $0.67663 | $0.683 | 2019-05-15 | 2019-04-15 |
| 2018-04-27 | $0.70352 | $0.725 | 2018-05-17 | 2018-04-20 |
| 2017-04-28 | $0.6275 | $0.616 | 2017-05-18 | |
| 2016-05-03 | $0.63338 | $0.62 | 2016-05-18 | 2016-05-04 |
The table below shows UCB S.A. (UCBJY) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
UCB S.A. (UCBJY) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Ipsen S.A. (IPSEY) | 0.01% |
| HOYA Corporation (HOCPF) | 0.01% |
| Daiichi Sankyo Company, Limited (DSNKY) | 0.03% |
| CSL Limited (CMXHF) | 0.04% |
| Lonza Group AG (LZAGF) | 0.01% |
| Lonza Group AG (LZAGY) | 0.01% |
| Daiichi Sankyo Company, Limited (DSKYF) | 0.03% |
| WuXi AppTec Co., Ltd. (WUXIF) | 0.02% |
| Haleon plc (HLNCF) | 0.02% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like UCB S.A. (UCBJY) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is UCBJY’s dividend yield?
What is the difference between regular and special dividends?
Has UCBJY increased its dividends over time?
Why might dividend history data be delayed?
How often does UCBJY pay dividends?
What factors impact UCBJY's dividend payments?
Can dividends change over time?
What is UCBJY’s next dividend date?